|Articles|May 21, 2019
I-ACT for Children Selects Advarra as Central IRB
Advertisement
Advarra has announced that it has been selected by the Institute for Advanced Clinical Trials for Children to provide central institutional review board services to the organization’s pediatric clinical trial site network. I-ACT for Children currently includes 44 U.S. pediatric research sites.
For further details, click
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
NEJM Retracts Tavneos Trial Paper as FDA, EMA Both Move to Pull Amgen Drug From Market
2
ACT Brief: Tavneos Trial Integrity Issues, Selective Safety Data Regulatory Pathways, and FDA PreCheck Program Launch
3
ACT Brief: Real-Time Trial Infrastructure Gaps, Built-In Data Security, and AI-Enabled CDMO Value
4
Real-Time Clinical Trials: What the FDA's Push Toward Continuous Oversight Means for Sponsors
5